Featured Research

from universities, journals, and other organizations

Gene Variant Discovery Could Save Blood In Surgery; Factor V Found In Bleeders, Variant In People Who Clot

Date:
February 26, 2003
Source:
Vanderbilt University Medical Center
Summary:
Bleeding after cardiac surgery is a major clinical problem, consuming up to 20 percent of the nation’s blood supply. Despite some understanding of the risk factors that contribute to increased blood loss, there is still considerable patient-to-patient variability, said Dr. Brian S. Donahue, assistant professor of Anesthesiology at Vanderbilt University Medical Center.

Bleeding after cardiac surgery is a major clinical problem, consuming up to 20 percent of the nation’s blood supply. Despite some understanding of the risk factors that contribute to increased blood loss, there is still considerable patient-to-patient variability, said Dr. Brian S. Donahue, assistant professor of Anesthesiology at Vanderbilt University Medical Center.

Donahue and colleagues are the first to show that a common genetic variation contributes to a patient’s tendency to suffer bleeding complications. The investigators report Feb. 25 in Circulation that cardiac surgery patients who have a different genetic form of one clotting factor lose less blood and are less likely to receive blood transfusions.

The findings herald a new era in medicine, one in which therapies will be customized for individual patients, based in part on the genes they carry. That is the hope anyway, Donahue said. “If we can outline a patient’s specific risk factors for given complications, then we can better tailor our therapeutic approach,” he said.

The current study focuses on factor V (“factor five”), one of the proteins essential to normal blood clotting. A variant form of the gene, called factor V Leiden, is present in about five percent of the white population in the United States, making it one of the most common inherited blood coagulation mutations. Individuals with factor V Leiden are at increased risk of forming blood clots, especially deep venous thromboses.

Because factor V Leiden carriers have blood with an increased tendency to clot, Donahue and colleagues wondered whether the mutation might actually protect against blood loss and transfusion in patients undergoing cardiac surgery.

They enrolled 517 cardiac surgery patients in the study, 26 of whom turned out to have one copy of the factor V Leiden gene (and one normal factor V gene). By measuring multiple variables and performing statistical comparisons, the investigators were able to demonstrate that patients with a factor V Leiden gene lost about a third less blood compared to patients with two normal factor V genes. In addition, about half of the factor V Leiden patients received blood transfusion after surgery, compared with nearly three-fourths of the patients without factor V Leiden.

The study is the first to link a common genetic variant to a clinically relevant outcome of cardiac surgery, Donahue said. “You’re almost twice as likely to leave the hospital free of a blood transfusion if you have factor V Leiden versus if you don’t,” he said.

The current findings demonstrate that factor V Leiden offers a protective effect with respect to blood loss and transfusion after cardiac surgery. But the gene variant may also play a sinister role.

“The question now is does factor V Leiden place cardiac surgery patients at increased risk for thrombosis, a potentially catastrophic complication,” Donahue said. Ongoing research will assess the impact of factor V Leiden on thrombosis following surgery. If factor V Leiden increases risk for thrombosis, genetic screening for the mutation could become routine.

While the current findings won’t immediately change clinical practice, Donahue said, they provide evidence that genetic variation impacts important surgical outcomes, supporting the need for additional studies in this area.

Dr. Jeffrey R. Balser, James Tayloe Gwathmey Professor and Chair of Anesthesiology, hopes to increase this type of research at Vanderbilt by developing the first major center for genomics in perioperative medicine. “This paper helps put us on the map,” Balser said.

Physician-scientists like Donahue who straddle laboratory bench and patient bedside are key to these efforts and are aided in developing their research projects by the Vanderbilt Physician Scientist Development Program (VPSD), which Balser founded and directs.

The VPSD provides two years of salary support to new physician-scientists so that they can spend 75 percent of their time engaged in research.

“The VPSD was a program essential for getting my project off the ground,” said Donahue, who was mentored by senior scientist Dr. Alfred L. George Jr., Grant W. Liddle Professor of Medicine. “It bridged the gap for me, allowing me the time to gather data so I could submit my own NIH application.”

“The VPSD has been phenomenally successful,” Donahue added. “There are probably at least a dozen federal grants now at Vanderbilt that were made possible by the VPSD.”

Donahue’s co-authors on the Circulation paper are Drs. George, David Gailani, Michael S. Higgins, and Davis C. Drinkwater. The research was supported by the National Institutes of Health and by a Clinical Research Starter Grant from the Foundation for Anesthesia Education and Research and Astra-Zeneca Pharmaceuticals.


Story Source:

The above story is based on materials provided by Vanderbilt University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Vanderbilt University Medical Center. "Gene Variant Discovery Could Save Blood In Surgery; Factor V Found In Bleeders, Variant In People Who Clot." ScienceDaily. ScienceDaily, 26 February 2003. <www.sciencedaily.com/releases/2003/02/030226073445.htm>.
Vanderbilt University Medical Center. (2003, February 26). Gene Variant Discovery Could Save Blood In Surgery; Factor V Found In Bleeders, Variant In People Who Clot. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2003/02/030226073445.htm
Vanderbilt University Medical Center. "Gene Variant Discovery Could Save Blood In Surgery; Factor V Found In Bleeders, Variant In People Who Clot." ScienceDaily. www.sciencedaily.com/releases/2003/02/030226073445.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins